Add description, images, menus and links to your mega menu
A column with no settings can be used as a spacer
Link to your collections, sales and even external links
Add up to five columns
Add description, images, menus and links to your mega menu
A column with no settings can be used as a spacer
Link to your collections, sales and even external links
Add up to five columns
September 05, 2022 6 min read
The hemp legalization in 2018 led to the increased production of CBD for medical and recreational use. This article will focus on CBD, the endocannabinoid system, how CBD interacts with this vital system, and the benefits of CBD for the endocannabinoid system.
Clinical trials and studies over the past few years show that chemical compounds in the cannabis plant have various health properties. Regardless of how they affect your psychology during recreational use, the marijuana plant contains a compound called Cannabidiol (CBD), which greatly impacts human health. CBD has gained popularity because it provides these benefits without psychoactive effects.
However, it doesn't work alone in most causes. Scientists have discovered that humans and mammals generally have an extensive network of endocannabinoid receptors. The endocannabinoid system (ECS) helps maintain internal body balances, relieves pain, inflammation, and anxiety, and improves appetite and sleep quality; others are still under research. CBD interacts with the system to provide effective and efficient results.
CBD is an active chemical compound derived from the cannabis sativa plant. It is largely extracted from the leaves and flowers of the hemp plant. The plant has a higher compound concentration compared to other cannabis plant classes. CBD is a prevalent cannabinoid since the hemp plant is legal in most USA states. The plant has a low tetrahydrocannabinoid (THC) concentration, which is common to marijuana users because it causes highness. In addition to the CBD regime, the Food and Drug Administration (FDA) has recently approved the first cannabis-derived medicine, Epidiolex, which contains CBD compounds for treating rare forms of epilepsy.
McFadden et al. (2021) suggested that CBD manufacturers use different extraction techniques, resulting in three types of CBD compounds. Each type has its composition, cons, and pros, depending on how they interact with ECS. They include:
Our bodies have a network of neuromodulatory receptors called endocannabinoids. The system is similar to the endocannabinoids in CBD and primarily exists in humans and other mammals. Lowe et al. (2021) explained that the ECS is a complex cell signing system that keeps our bodies in a homeostatic state. Additionally, the system regulates body pain, stress, energy levels, appetite, cardiovascular function, reproduction, sleep, and more to achieve internal homeostasis.
It consists of three main components: receptors, endocannabinoids, and enzymes breaking down the cannabinoids. The system exists throughout the body, from the central nervous system, the skin, the spinal cord, and the immune cells in the blood, to the neurons in the brain.
People can have endocannabinoid deficiency wherein a patient is not producing enough cannabinoids, thus resulting in complications such as depression, chronic anxiety, inflammation, PSTD, chronic pain, and fibromyalgia. CBD, when consumed orally, in injections, or applied to the skin, has proven to control some of the symptoms caused by this deficiency.
According to Cooray et al. (2020), bodies naturally produce endocannabinoids. They are two types:
CBD helps the body produce more endocannabinoid compounds in case of inadequate endocannabinoids. It also prevents the body's cannabinoids from being broken down, thus improving their efficacy.
They are known to bind with body cannabinoids to trigger cell responses. In case of deficiency, they can bind with consumed CBD compounds resulting in the same functionality. There are two main types:
CB1 is located in the central nervous system and is responsible for motor functions. CBD does not bind with these receptors but promotes neuro-transmission of the receptors in tackling the imbalance.
CB2 is found in the immune system and plays are role in neuroinflammation and neuroprotection. Neuroprotective and anti-inflammatory properties characterize CBD; therefore, it binds with receptors activating various pathways to increase feelings of improved mood and relaxation, thus tackling imbalances such as pain, anxiety, and inflammation.
Moreover, brain cells communicate with the rest of the body by sending chemical signals called neurotransmitters which coordinate and regulate everything you feel, do or think. CBD perceives the neurons (brain cells) on how they respond to emotions and increases neurotransmitters' signaling to the affected area.
They are responsible for breaking down and production of anandamide endocannabinoids. CBD triggers the enzymes in producing the body's cannabinoids and delays their breakdown resulting in maintaining homeostasis. In addition, CBD triggers enzymes that produce the hormone serotonin, the stress-relieving hormone that promotes sleep and reduces high anxiety and stress levels. Learn more about the science behind cbd
Pamplona et al. (2018) explained that when CBD interacts with the system, it results in the following health benefits:
Clinical studies and trials are being conducted to establish the relationship between CBD and ECS further. The ECS plays a major role in regulating and maintaining stable internal processes. It stabilizes conditions such as pain, anxiety, stress, inflammation, memory, and many others under investigation. Furthermore, CBD activates the system in its functions, resulting in better, more effective, and more efficient tackling of the imbalance. In case of endocannabinoid shortage, CBD triggers the production of more endocannabinoids and reduces their breakdown to ensure they efficiently tackle these health problems. Therefore, the interaction between CBD and ECS results in controlling symptoms of diseases such as AIDS, PTSD, GAD, Parkinson's disease, Alzheimer's disease, arthritis, acne, diabetes, insomnia, and ADHD.
McFadden, B. R., & Malone, T. (2021). Homegrown perceptions about the medical use and potential abuse of CBD and THC. Addictive behaviors, 115, 106799.
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021). The endocannabinoid system: A potential target for the treatment of various diseases. International Journal of Molecular Sciences, 22(17), 9472.
Cooray, R., Gupta, V., & Suphioglu, C. (2020). A review is a review of current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson's and Alzheimer's diseases. Molecular Neurobiology, 57(11), 4878-4890.
Pamplona, F. A., Da Silva, L. R., & Coan, A. C. (2018). Potential clinical benefits of CBD-rich cannabis extracts over purified CBD in treatment-resistant epilepsy: observational data meta-analysis. Frontiers in neurology, 759.
Buy 1 Get 1 Free limited time offer on selected CBD products. Subscribe to our newsletter to enter our weekly prize draw.